Jiang L - Search Results

1

Efficacy and safety of levetiracetam versus (fos)phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials.

Feng Y, Chen Y, Jia Y, Wang Z, Wang X, Jiang L, Ai C, Li W, Liu Y. Feng Y, et al. Among authors: jiang l. Seizure. 2021 Oct;91:339-345. doi: 10.1016/j.seizure.2021.07.012. Epub 2021 Jul 13. Seizure. 2021. PMID: 34284302 Free article. Review.

2

Preparation of an Electrically Conductive Graphene Oxide/Chitosan Scaffold for Cardiac Tissue Engineering.

Jiang L, Chen D, Wang Z, Zhang Z, Xia Y, Xue H, Liu Y. Jiang L, et al. Appl Biochem Biotechnol. 2019 Aug;188(4):952-964. doi: 10.1007/s12010-019-02967-6. Epub 2019 Feb 11. Appl Biochem Biotechnol. 2019. PMID: 30740624

3

The pharmacokinetic interaction between irinotecan and sunitinib.

Jiang L, Wang L, Zhang Z, Wang Z, Wang X, Wang S, Luan X, Xia Y, Liu Y. Jiang L, et al. Cancer Chemother Pharmacol. 2020 Feb;85(2):443-448. doi: 10.1007/s00280-019-03985-1. Epub 2019 Nov 5. Cancer Chemother Pharmacol. 2020. PMID: 31691077

4

Pterostilbene supplements carry the risk of drug interaction via inhibition of UDP-glucuronosyltransferases (UGT) 1A9 enzymes.

Jiang L, Zhang Z, Xia Y, Wang Z, Wang X, Wang S, Wang Z, Liu Y. Jiang L, et al. Toxicol Lett. 2020 Mar 1;320:46-51. doi: 10.1016/j.toxlet.2019.12.008. Epub 2019 Dec 5. Toxicol Lett. 2020. PMID: 31812603

5

Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactions.

Wang Z, Wang X, Jia Y, Yin H, Feng Y, Jiang L, Cao J, Liu Y. Wang Z, et al. Among authors: jiang l. Biopharm Drug Dispos. 2020 Jun;41(6):231-238. doi: 10.1002/bdd.2241. Epub 2020 Jun 22. Biopharm Drug Dispos. 2020. PMID: 32436276

6

Piceatannol exhibits potential food-drug interactions through the inhibition of human UDP-glucuronosyltransferase (UGT) in Vitro.

Jiang L, Wang Z, Wang X, Wang S, Wang Z, Liu Y. Jiang L, et al. Toxicol In Vitro. 2020 Sep;67:104890. doi: 10.1016/j.tiv.2020.104890. Epub 2020 May 22. Toxicol In Vitro. 2020. PMID: 32446839

7

Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions.

Wang X, Wang Z, Wang Z, Chen X, Yin H, Jiang L, Cao J, Liu Y. Wang X, et al. Among authors: jiang l. Toxicol Lett. 2021 Mar 1;338:51-57. doi: 10.1016/j.toxlet.2020.12.001. Epub 2020 Dec 5. Toxicol Lett. 2021. PMID: 33290829

8

Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor.

Jiang L, Zhang Z, Wang Z, Liu Y. Jiang L, et al. Open Life Sci. 2021 Apr 3;16(1):303-310. doi: 10.1515/biol-2021-0036. eCollection 2021. Open Life Sci. 2021. PMID: 33851030 Free PMC article.

9

Risk prediction of drug-drug interaction potential of phenytoin and miconazole topical formulations.

Li W, Wang Z, Wang X, Cao X, Bi C, Jiang L, Cui S, Liu Y. Li W, et al. Among authors: jiang l. Chem Biol Interact. 2021 Jul 1;343:109498. doi: 10.1016/j.cbi.2021.109498. Epub 2021 May 4. Chem Biol Interact. 2021. PMID: 33961833

10

Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.

Wang X, Wang Z, Fan X, Yan M, Jiang L, Xia Y, Cao J, Liu Y. Wang X, et al. Among authors: jiang l. Toxicol Appl Pharmacol. 2021 Aug 1;424:115595. doi: 10.1016/j.taap.2021.115595. Epub 2021 May 24. Toxicol Appl Pharmacol. 2021. PMID: 34038714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,722 results

Search Page

Filters